Stricker Learning Span criterion validity: a remote self-administered multi-device compatible digital word list memory measure shows similar ability to differentiate amyloid and tau PET-defined biomarker groups as in-person Auditory Verbal Learning Test

Author:

Stricker Nikki H.ORCID,Stricker John L.,Frank Ryan D.,Fan Winnie Z.,Christianson Teresa J.,Patel Jay S.,Karstens Aimee J.,Kremers Walter K.,Machulda Mary M.,Fields Julie A.,Graff-Radford Jonathan,Jack Clifford R.,Knopman David S.,Mielke Michelle M.ORCID,Petersen Ronald C.

Abstract

AbstractObjectiveThe Stricker Learning Span (SLS) is a computer-adaptive digital word list memory test specifically designed for remote assessment and self-administration on a web-based multi-device platform (Mayo Test Drive). We aimed to establish criterion validity of the SLS by comparing its ability to differentiate biomarker-defined groups to the person-administered Rey’s Auditory Verbal Learning Test (AVLT).Participants and MethodsParticipants (N=353; mean age=71, SD=11; 93% cognitively unimpaired [CU]) completed the AVLT during an in-person visit, the SLS remotely (within 3 months) and had brain amyloid and tau PET scans available (within 3 years). Overlapping groups were formed for 1) those on the Alzheimer’s disease (AD) continuum (amyloid PET positive, A+, n=125) or not (A-, n=228), and those with biological AD (amyloid and tau PET positive, A+T+, n=55) vs no evidence of AD pathology (A-T-, n=195). Analyses were repeated among CU participants only.ResultsThe SLS and AVLT showed similar ability to differentiate biomarker-defined groups when comparing AUROCs (p’s>.05). In logistic regression models, SLS contributed significantly to predicting biomarker group beyond age, education and sex, including when limited to CU participants. Medium (A- vs A+) to large (A-T- vs A+T+) unadjusted effect sizes were observed for both SLS and AVLT. Learning and delay variables were similar in terms of ability to separate biomarker groups.ConclusionsRemotely administered SLS performed similarly to in-person-administered AVLT in its ability to separate biomarker-defined groups, providing evidence of criterion validity. Results suggest the SLS may be sensitive to detecting subtle objective cognitive decline in preclinical AD.

Publisher

Cold Spring Harbor Laboratory

Reference61 articles.

1. Alzheimer's disease drug development pipeline: 2021

2. The New Normal in Clinical Trials: Decentralized Studies

3. EARLY DETECTION OF MILD COGNITIVE IMPAIRMENT (MCI) IN PRIMARY CARE

4. RATIONALE FOR EARLY DIAGNOSIS OF MILD COGNITIVE IMPAIRMENT (MCI) SUPPORTED BY EMERGING DIGITAL TECHNOLOGIES

5. Bauer, R. M. & Bilder, R. M. in APA Handbook of Neuropsychology Vol. 2: Neuroscience and Neuromethods (eds Gregory G. Brown , Tricia Z. King , Kathleen Y. Haaland , & Bruce Crosson ) (American Psychological Association, 2023, in press).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3